Emtricitabine Completed Phase N/A Trials for Human Immunodeficiency Virus (HIV) Infections

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02411630Factors Affecting PrEP Adherence
NCT01769469Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
NCT00851799Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
NCT02367807PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color
NCT03049176The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)
NCT00666055Sex, Aging and Antiretroviral Pharmacokinetics
NCT00705419Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)
NCT00729573Bone Mineral Density Substudy - An Ancillary Study to MTN-003
NCT01180075Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population